These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38786128)

  • 21. Heterogeneity of Staphylococcus epidermidis in prosthetic joint infections: time to reevaluate microbiological criteria?
    Widerström M; Stegger M; Johansson A; Gurram BK; Larsen AR; Wallinder L; Edebro H; Monsen T
    Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):87-97. PubMed ID: 34599708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of vancomycin to cefazolin is often unnecessary for preoperative antibiotic prophylaxis during total joint arthroplasties.
    Bains SS; Dubin JA; Hameed D; Chen Z; Moore MC; Shrestha A; Nace J; Delanois RE
    Arthroplasty; 2024 Mar; 6(1):20. PubMed ID: 38459606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and microbiology of prosthetic joint infections: a nine-year, single-center experience in Pavia, Northern Italy.
    Mussa M; Manciulli T; Corbella M; Mariani B; Cambieri P; Gipsz N; Scudeller L; Abbott DM; Brunetti E; Mosconi M; Benazzo F; Orsolini P
    Musculoskelet Surg; 2021 Aug; 105(2):195-200. PubMed ID: 31993973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methicillin-Resistant
    Månsson E; Tevell S; Nilsdotter-Augustinsson Å; Johannesen TB; Sundqvist M; Stegger M; Söderquist B
    Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33525409
    [No Abstract]   [Full Text] [Related]  

  • 25. Trends in microbiological profiles and antibiotic resistance in periprosthetic joint infections.
    Hu L; Fu J; Zhou Y; Chai W; Zhang G; Hao L; Chen J
    J Int Med Res; 2021 Mar; 49(3):3000605211002784. PubMed ID: 33787371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA.
    Liu C; Kakis A; Nichols A; Ries MD; Vail TP; Bozic KJ
    Clin Orthop Relat Res; 2014 Jan; 472(1):227-31. PubMed ID: 23645338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
    Nodzo SR; Boyle KK; Frisch NB
    J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility.
    Jarløv JO
    APMIS Suppl; 1999; 91():1-42. PubMed ID: 10230367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should Preoperative Antibiotics Be Tailored According to Patient's Comorbidities and Susceptibility to Organisms?
    Tan TL; Gomez MM; Kheir MM; Maltenfort MG; Chen AF
    J Arthroplasty; 2017 Apr; 32(4):1089-1094.e3. PubMed ID: 28040397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic Prophylaxis with Cefazolin Is Associated with Lower Shoulder Periprosthetic Joint Infection Rates Than Non-Cefazolin Alternatives.
    Marigi EM; Bartels DW; Yoon JH; Sperling JW; Sanchez-Sotelo J
    J Bone Joint Surg Am; 2022 May; 104(10):872-880. PubMed ID: 35188900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic bacteria characteristics and drug resistance in acute, delayed, and chronic periprosthetic joint infection: A retrospective analysis of 202 patients.
    Chang Y; Li Y; Fan T; Jiang K; Lv J; Huang J
    Int Wound J; 2023 Oct; 20(8):3315-3323. PubMed ID: 37186450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip Replacement.
    Rivera A; Sánchez A; Luque S; Mur I; Puig L; Crusi X; González JC; Sorlí L; González A; Horcajada JP; Navarro F; Benito N
    Antibiotics (Basel); 2020 Dec; 10(1):. PubMed ID: 33375415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
    Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
    Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-cefazolin antibiotic prophylaxis is associated with higher rates of elbow periprosthetic joint infection.
    Nieboer M; Braig Z; Rosenow C; Marigi E; Tande A; Barlow J; Sanchez-Sotelo J; O'Driscoll S; Morrey M
    J Shoulder Elbow Surg; 2024 Apr; 33(4):940-947. PubMed ID: 38104721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empiric antibiotic therapy in early periprosthetic joint infection: a retrospective cohort study.
    Scholten R; Klein Klouwenberg PMC; Gisolf JEH; van Susante JLC; Somford MP
    Eur J Orthop Surg Traumatol; 2023 Jan; 33(1):29-35. PubMed ID: 34705102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections.
    Lourtet-Hascoët J; Félicé MP; Bicart-See A; Bouige A; Giordano G; Bonnet E
    Epidemiol Infect; 2018 Oct; 146(14):1771-1776. PubMed ID: 29880073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.
    Tevell S; Claesson C; Hellmark B; Söderquist B; Nilsdotter-Augustinsson Å
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):911-7. PubMed ID: 24338092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing Microorganism Profile in Early and Late Prosthetic Joint Infections Following Primary Total Knee Arthroplasty - Implications for Empiric Antibiotic Treatment.
    Kim K; Zhu M; Coleman B; Munro JT; Young SW
    J Arthroplasty; 2022 Sep; 37(9):1858-1864.e1. PubMed ID: 35460813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review.
    Matt M; Duran C; Courjon J; Lotte R; Moing VL; Monnin B; Pavese P; Chavanet P; Khatchatourian L; Tattevin P; Cattoir V; Lechiche C; Illes G; Lacassin-Beller F; Senneville E; Dinh A;
    J Glob Antimicrob Resist; 2021 Jun; 25():341-345. PubMed ID: 33962065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.